Kadlec Robert Peter - Insider Non-Derivative Transactions at MiNK Therapeutics, Inc. (INKT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 1, 2025, Kadlec Robert Peter's relationship to MiNK Therapeutics, Inc. (INKT) is Director, and currently has 19,126 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other INKT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Kadlec Robert Peter - Insider Non-Derivative Transactions of INKT Common Stock

Kadlec Robert Peter - Insider Non-Derivative Transactions at INKT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 2, 2025	Acquisition -- (Common Stock)	1218	11.09	19126
Sep 3, 2025	Acquisition -- (Common Stock)	975	13.86	17908
Jun 3, 2025	Acquisition -- (Common Stock)	1883	7.17	4647
Mar 4, 2025	Acquisition -- (Common Stock)	1536	8.79	2764
Dec 2, 2024	Acquisition -- (Common Stock)	12286	0.73	12286